Adjuvant_whole-abdominal_radiation_therapy_in_uterine_papillary_serous_carcinoma._Nine_patients_from_34_to_74_years_of_age_(median,_67_years_of_age)_with_uterine_papillary_serous_carcinoma_(UPSC)_were_treated_with_whole-abdominal_radiation_therapy_(WART)_on_an_adjuvant_basis_after_cytoreductive_surgery._All_patients_were_treated_with_megavoltage_photons_to_an_abdominopelvic_field_to_a_median_dose_of_2500_cGy,_with_continued_treatment_to_a_whole_pelvic_field_to_a_median_dose_of_4500_cGy._Three_patients_received_additional_boost_to_the_vaginal_apex._Follow-up_time_ranged_from_6_to_31_months_(median,_25_months)_after_completion_of_WART._Six_patients_had_recurrent_disease_at_5_to_20_months_(median,_7.5_months)._Four_of_these_patients_died_of_their_disease_during_the_follow-up_period._Three_of_six_patients_in_whom_treatment_failed_had_disease_at_the_vaginal_apex._None_of_these_patients_received_boost_radiation_therapy_to_that_site._In_contrast,_two_of_three_patients_remaining_disease_free_were_treated_with_additional_vaginal_apex_irradiation._Based_on_these_results,_the_authors_do_not_routinely_recommend_WART_for_adjuvant_treatment_of_UPSC._They_do,_however,_recommend_vaginal_apex_irradiation_for_these_patients.